RE: 50’s incoming22 Sep 2022 19:30
whooooooooooooooooooooooooooooooo
RNS Number : 3711A
Iconic Labs PLC
22 September 2022
Iconic Labs PLC
22 September 2022
Iconic Labs Plc - In Administration ("Iconic Labs" or the "Company")
Notice of Results of Creditors Meeting and General Meeting of Shareholders
Iconic Labs Plc (LSE:ICON hereby advises that it held a general meeting ("GM") earlier today.
The CVA Proposal was approved by the requisite majorities of the creditors at a meeting of the creditors held today at 11am.
At a meeting of the shareholders of the Company, held today at 2.00pm, all resolutions were duly passed on a poll vote.
Details of the proxy voting are shown in the table below.
Votes % Votes % Votes Total Votes Withheld
For Against
Ordinary resolutions:
---------------- ------- --------------- ------ ---------------- --------------
(1) Approval of the Company
Voluntary Arrangement ("CVA")
. 10,009,834,608 97.49 257,331,813 2.51 10,267,166,421 48,068,796
---------------- ------- --------------- ------ ---------------- --------------
(2) To empower the directors
to generally allot relevant
equity securities in respect
of the CVA 10,240,735,765 99.74 26,430,656 0.26 10,267,166,421 48,068,796
---------------- ------- --------------- ------ ---------------- --------------
(3) To empower the directors
to generally allot relevant
equity securities to promote
the success of the Company 10,240,225,765 99.74 26,430,656 0.26 10,266,656,421 48,578,796
---------------- ------- --------------- ------ ---------------- --------------
Special resolutions:
---------------- ------- --------------- ------ ---------------- --------------
(4) Subject to the passing
of Resolution 2, to disapply
the pre-emptive rights in
respect of the relevant
equity securities to be
allotted in respect of CVA
Proposal . 10,009,324,608 97.49 257,331,813 2.51 10,266,656,421 48,578,796
---------------- ------- --------------- ------ ---------------- --------------
(5) Subject to the passing
of Resolution 3, to disapply
the pre-emptive rights in
respect of the relevant
equity securities to be
allotted to promote the
success of the Company. 10,240,225,765 99.74 26,430,656 0.26 10,266,656,421 48,578,796
---------------- ------- --------------- ------ ----------------Sound familiar ?.x